Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: A medical chart review across ten centers in five European countries

  1. Porta, C.
  2. Levy, A.
  3. Hawkins, R.
  4. Castellano, D.
  5. Bellmunt, J.
  6. Nathan, P.
  7. Mcdermott, R.
  8. Wagstaff, J.
  9. Donnellan, P.
  10. Mccaffrey, J.
  11. Vekeman, F.
  12. Neary, M.P.
  13. Diaz, J.
  14. Mehmud, F.
  15. Duh, M.S.
Revue:
Cancer Medicine

ISSN: 2045-7634

Année de publication: 2014

Volumen: 3

Número: 6

Pages: 1517-1526

Type: Article

DOI: 10.1002/CAM4.302 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus